If someone told you that asthma would help you win gold at the Olympics, would you believe them? Well according to a new study, athletes with asthma are more likely to win at the Winter Games than those without these breathing problems. Claire Maldarelli, Assistant Editor at Popular Science, explains the science behind the study.
The issue of asthma and inhalers has been divisive for a long time within the International Olympic Committee. Until recently many types of inhalers were banned. The rules and regulations on medications still change regularly.
Amgen Foundation is doubling down on its support for virtual education platform Khan Academy with a $3 million grant.
Sorrento Therapeutics has been approved by the FDA to move forward with Phase 2 trials of its 'Abivertinib' study. ICU patients in some SoCal hospitals will undergo testing of the orally administered drug.
President Donald Trump sought to paint a rosier picture of the coronavirus for the nation on Tuesday but conceded the pandemic is likely to “get worse before it gets better.”
The Justice Department says hackers working with the Chinese government targeted firms developing coronavirus vaccines and stole hundreds of millions of dollars worth of intellectual property and trade secrets from companies worldwide.
The Amal, or Hope, orbiter is the Arab world’s first interplanetary mission.
Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
Teams of military medics were deployed in Texas and California to help hospitals deluged by coronavirus patients. Miami area authorities, meanwhile, began stepping up enforcement Friday of a mask requirement.
Target and CVS Health have joined the list of the nation’s largest retailers that will require customers to wear masks as cases of COVID-19 spike.
The small San Diego biotech company specializes in treating different types of inflammation.
